Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/17212
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSANYAL, Shreosi-
dc.contributor.authorVANCAUTEREN, Mark-
dc.date.accessioned2014-10-07T10:17:37Z-
dc.date.available2014-10-07T10:17:37Z-
dc.date.issued2014-
dc.identifier.citationInnovation Forum VI - 2014, Crisis, innovation and transition, Paris, France, 1-3 October, 2014-
dc.identifier.urihttp://hdl.handle.net/1942/17212-
dc.language.isoen-
dc.titleR&D and its determinants: A study of the pharmaceutical firms in the Netherlands-
dc.typeConference Material-
local.bibliographicCitation.conferencedate1-3 October, 2014-
local.bibliographicCitation.conferencenameInnovation Forum VI - 2014, Crisis, innovation and transition-
local.bibliographicCitation.conferenceplaceParis, France-
local.bibliographicCitation.jcatC2-
local.type.refereedRefereed-
local.type.specifiedPaper-
item.accessRightsClosed Access-
item.fulltextNo Fulltext-
item.fullcitationSANYAL, Shreosi & VANCAUTEREN, Mark (2014) R&D and its determinants: A study of the pharmaceutical firms in the Netherlands. In: Innovation Forum VI - 2014, Crisis, innovation and transition, Paris, France, 1-3 October, 2014.-
item.contributorSANYAL, Shreosi-
item.contributorVANCAUTEREN, Mark-
Appears in Collections:Research publications
Show simple item record

Page view(s)

24
checked on Nov 7, 2023

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.